Company profile

Sun Pharmaceutical Industries

Diversified pharma

SUNPHARMA · NSE · India

Public Market Listing

SUNPHARMANSE

NSE primary exchange listing

Live quotes, historical charts, and market capitalization for Sun Pharmaceutical Industries are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
3Approved
0Phase 3 / Filed
1Phase 1–2 / Early
6Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
Duloxetine(Cymbalta)
Approved
Serotonin/norepinephrine transporter · Serotonin and norepinephrine transporters (SERT/NET)Small molecule
Diabetic Peripheral Neuropathic Pain
Phenobarbital sodium injection (Sezaby)
Approved
GABA-A receptorSmall molecule
Epilepsy
tildrakizumab(Ilumya)
Approved
IL-23 p19Monoclonal antibody
Psoriatic ArthritisAtopic DermatitisPsoriasis
GL0034
Phase 2
GLP-1 receptorPeptide
Obesity

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.